Abstract:Chronic heart failure is often associated with sympathoexcitation and blunted arterial baroreflex function. These phenomena have been causally linked to elevated central ANG II mechanisms. Recent studies have shown that NAD(P)H oxidase-derived reactive oxygen species (ROS) are important mediators of ANG II signaling and therefore might play an essential role in these interactions. The aims of this study were to determine whether central subchronic infusion of ANG II in normal animals has effects on O-2(-) production and expression of NAD( P) H oxidase subunits as well as ANG II type 1 (AT(1)) receptors in the rostral ventrolateral medulla (RVLM). Twenty-four male New Zealand White rabbits were divided into four groups and separately received a subchronic intracerebroventricular infusion of saline alone, ANG II alone, ANG II with losartan, and losartan alone for 1 wk. On day 7 of intracerebroventricular infusion, mean arterial pressure (MAP), heart rate (HR), and renal sympathetic nerve activity (RSNA) values were recorded, and arterial baroreflex sensitivity was evaluated while animals were in the conscious state. We found that ANG II significantly increased baseline RSNA ( 161.9%; P < 0.05), mRNA and protein expression of AT1 receptors (mRNA, 66.7%; P < 0.05; protein, 85.1%; P < 0.05), NAD( P)H oxidase subunits (mRNA, 120.0-200.0%; P < 0.05; protein, 90.9-197.0%; P < 0.05), and O-2(-) production (83.2%; P < 0.05) in the RVLM. In addition, impaired baroreflex control of HR (Gainmax reduced by 48.2%; P < 0.05) and RSNA (Gainmax reduced by 53.6%; P < 0.05) by ANG II was completely abolished by losartan. Losartan significantly decreased baseline RSNA (-49.5%; P < 0.05) and increased baroreflex control of HR (Gainmax increased by 64.8%; P < 0.05) and RSNA (Gainmax increased by 67.9%; P < 0.05), but had no significant effects on mRNA and protein expression of AT(1) receptor and NAD(P)H oxidase subunits and O-2(-) production in the RVLM. These data suggest that in normal rabbits, NAD(P)H oxidase-derived ROS play an important role in the modulation of sympathetic activity and arterial baroreflex function by subchronic central treatment of exogenous ANG II via AT(1) receptors.

Effect Of Angiotensin Ii On Voltage-Gated Sodium Currents In Aortic Baroreceptor Neurons And Arterial Baroreflex Sensitivity In Heart Failure Rats

Angiotensin Ii-Induced Inhibition Of Sodium Currents In Aortic Baroreceptor Neurons Mediates Blunted Arterial Baroreflex Sensitivity In Heart Failure Rats

Elevated angiotensin II attenuates activation of voltage-gated sodium channels in heart failure rats: involvement of mitochondria-derived superoxide

Angiotensin II-superoxide-NFκB signaling and aortic baroreceptor dysfunction in chronic heart failure.

Reduced expression and activation of voltage-gated sodium channels contributes to blunted baroreflex sensitivity in heart failure rats.

Lowered Activation of Voltage‐gated Sodium Channels Contributes to Blunted Baroreflex Sensitivity in Heart Failure Rats

Imbalance of Angiotensin Receptor Expression and Function in the Spinal Cord: Potential Mechanism of Sympathetic Overactivity in Chf Rats

ANG II in the paraventricular nucleus potentiates the cardiac sympathetic afferent reflex in rats with heart failure.

Cardiac Sympathetic Afferent Stimulation Inhibits the Arterial Baroreflex in He Art Failure at the Level of the Nucleus Tractus Solitarius by an Angiotensin Ii Mechanism

Augmented Input from Cardiac Sympathetic Afferents Inhibits Baroreflex in Rats with Heart Failure

Angiotensin II enhances hyperpolarization-activated currents in rat aortic baroreceptor neurons: involvement of superoxide.

Sympathoexcitation in Chronic Heart Failure: Ang II Induced Inhibition of Voltage‐gated K + Channel, an in Vivo and in Vitro Study

Angiotensin II enhances carotid body chemoreflex control of sympathetic outflow in chronic heart failure rabbits.

In vivo transfection of manganese superoxide dismutase gene or nuclear factor κB shRNA in nodose ganglia improves aortic baroreceptor function in heart failure rats.

Neuronal Angiotensin II Type 1 Receptor Upregulation in Heart Failure

Altered Enac Is Associated With Aortic Baroreceptor Dysfunction In Chronic Heart Failure

Augmented input from cardiac sympathetic afferents inhibits the baroreflex in heart failure

Neuronal Angiotensin Ii Type 1 Receptor Upregulation In Heart Failure - Activation Of Activator Protein 1 And Jun N-Terminal Kinase

Increased Neuronal Discharge in the RVLM of Rats with Chronic Heart Failure is Mediated by AT1R

Sympathoexcitation by Central ANG II: Roles for AT1 Receptor Upregulation and NAD(P)H Oxidase in RVLM

Imbalance of Angiotensin Type 1 Receptor and Angiotensin Ii Type 2 Receptor in the Rostral Ventrolateral Medulla - Potential Mechanism for Sympathetic Overactivity in Heart Failure